Blog
Ketamine in Canada: From Anesthetic Medicine to Modern Mental Health Research
Ketamine has an unusual place in modern medicine.
Originally developed as an anesthetic, it has been used medically for decades. More recently, ketamine has attracted attention because of its dissociative effects and ongoing research into its potential role in treating certain mental health conditions.
This growing interest has also led to increased online searches for ketamine in Canada, ketamine therapy, ketamine treatment, ketamine research, and related topics.
But ketamine is not simply another psychedelic substance. It has established medical uses, a different pharmacological profile from classic psychedelics, and significant risks when used outside appropriate medical supervision.
So, what exactly is ketamine, why has it become such an important topic in mental health research, and what should Canadians know about it?
What Is Ketamine?
Ketamine is a fast-acting anesthetic that can produce dissociation, a state in which a person may feel separated from their body or surroundings.
Health Canada describes ketamine as a dissociative drug that can alter the way people experience pain, sight, sound, and their relationship with their surroundings. It is authorized in Canada as a general anesthetic for human medical use and also has veterinary applications.
Unlike substances that primarily produce classic psychedelic effects, ketamine belongs to a different pharmacological category.
Its dissociative properties are one reason it has attracted interest beyond anesthesia.
From Operating Rooms to Mental Health Research
Ketamine’s medical history began with anesthesia.
Because it acts relatively quickly and has pain-relieving and anesthetic properties, ketamine became an important medication in medical settings.
Over time, researchers began investigating other possible applications.
One particularly interesting area is mental health.
Researchers have been studying ketamine and related treatments for conditions such as depression, especially forms of depression that have not responded adequately to conventional treatments.
Canada’s clinical trial database continues to list research involving ketamine and depression. A clinical trial updated in July 2026, for example, is investigating ketamine in comparison with electroconvulsive therapy for depression.
This illustrates why ketamine continues to attract scientific attention.
Why Is Ketamine Being Studied for Depression?
Traditional antidepressants often take time to produce noticeable effects.
Ketamine has generated interest because some research has suggested that ketamine-based treatments can produce relatively rapid changes in depressive symptoms in certain clinical circumstances.
Researchers are investigating how ketamine affects brain signaling and whether those effects can help people whose depression has not responded sufficiently to other treatments.
However, this does not mean ketamine is appropriate for everyone with depression.
Treatment decisions depend on factors such as diagnosis, medical history, previous treatments, potential contraindications, and clinical supervision.
The distinction between research, medical treatment, and unsupervised use is extremely important.
Ketamine vs. Esketamine
One source of confusion surrounding ketamine treatment is the difference between ketamine and esketamine.
Ketamine is a mixture containing two molecular forms, commonly referred to as S-ketamine and R-ketamine.
Esketamine is the S-form of ketamine.
Health Canada has authorized esketamine under the brand name Spravato as a nasal spray for certain adults with major depressive disorder who have not responded adequately to other antidepressants or where urgent psychiatric care is required. Health Canada notes that its use is subject to controlled distribution and monitoring requirements.
This is different from using ketamine obtained outside an approved medical pathway.
What Does Ketamine Feel Like?
Ketamine can produce a range of subjective effects.
At medical doses, its anesthetic and analgesic properties are carefully managed by healthcare professionals.
Outside medical supervision, effects can become unpredictable.
Health Canada lists possible short-term psychological effects including:
- Dizziness
- Confusion
- Sleepiness
- Loss of coordination
- Feelings of weightlessness
- Changes in perception
- Vivid dreams
- Hallucinations
- Dissociation
Some people describe intense dissociation as feeling detached from their body or surroundings.
The experience can vary significantly depending on the person, the substance, the circumstances, and other factors.
Understanding the Dissociative Experience
Dissociation is one of the defining characteristics of ketamine.
A person may feel disconnected from their physical body, surroundings, emotions, or ordinary sense of time.
This can be fascinating from a neuroscience perspective because it provides researchers with an opportunity to study how the brain constructs our normal perception of self and reality.
However, dissociation is not inherently positive.
It can also involve confusion, fear, impaired coordination, hallucinations, or loss of awareness.
Health Canada warns that ketamine can affect a person’s ability to respond appropriately to their environment and can increase the risk of accidents and injuries.
Why Are People Talking About Ketamine and Mental Health?
The renewed interest in ketamine is part of a larger movement toward investigating new approaches to difficult-to-treat mental health conditions.
Research institutions across Canada are examining psychedelic and psychedelic-adjacent treatments.
The Centre for Addiction and Mental Health reported in June 2026 that its researchers are investigating psychedelic therapies and neuroplasticity, reflecting the broader scientific interest in how these substances may influence brain function and mental health outcomes.
Ketamine is part of this wider conversation, although it is pharmacologically distinct from classic psychedelics such as psilocybin and LSD.
Ketamine Is Not the Same as Psilocybin
Ketamine and psilocybin are sometimes discussed together because both can produce unusual changes in perception and consciousness.
However, they are fundamentally different substances.
| Ketamine | Psilocybin |
|---|---|
| Dissociative anesthetic | Classic psychedelic |
| Used medically as an anesthetic | Found naturally in certain mushroom species |
| Produces dissociation | Primarily produces psychedelic effects |
| Has established anesthetic applications | Research continues into therapeutic applications |
| Esketamine has an approved Canadian indication | No approved therapeutic psilocybin product in Canada |
| Controlled substance in Canada | Controlled substance in Canada |
Understanding this distinction is important when researching psychedelic-related treatments.
What Are the Medical Uses of Ketamine?
Ketamine has legitimate medical uses.
In Canada, Health Canada states that ketamine is authorized as a general anesthetic for humans. It is also authorized for veterinary use as a general anesthetic.
Medical professionals may use ketamine in controlled environments where patients can be monitored.
The medication’s effects on consciousness, pain perception, and the nervous system make appropriate medical oversight particularly important.
Ketamine and Pain Management
Ketamine’s history in medicine is not limited to anesthesia.
Its effects on pain signaling have also contributed to research into pain management.
However, the appropriate use of ketamine for pain depends on the medical condition, formulation, route of administration, patient characteristics, and clinical judgment.
Consumers should be cautious about online claims suggesting that ketamine is a universal treatment for pain or other medical conditions.
What Are the Risks of Ketamine?
Ketamine can produce significant physical and psychological effects.
Health Canada identifies possible short-term effects such as:
- Increased heart rate
- Increased blood pressure
- Numbness
- Blurred vision
- Confusion
- Loss of coordination
- Difficulty breathing
- Loss of consciousness
- Nausea and vomiting
Higher amounts can increase the risk of severe outcomes, including coma and death.
This is one reason medical ketamine should be distinguished from illicit ketamine.
Long-Term Ketamine Use
Repeated ketamine use can produce additional problems.
Health Canada reports that regular long-term use may be associated with urinary and bladder problems, including inflammation, painful urination, frequent urination, and incontinence. Long-term effects can also include memory and attention problems.
Ketamine can also lead to tolerance and dependence.
This means that treating ketamine as a harmless recreational substance can underestimate its potential risks.
Ketamine and Alcohol or Other Depressants
Combining ketamine with other substances can increase risk.
Health Canada specifically warns that using ketamine together with other central nervous system depressants, including alcohol and opioids, can cause dangerous respiratory depression.
Because interactions can be unpredictable, combining ketamine with other psychoactive substances should not be treated casually.
Why Online Ketamine Claims Require Caution
Search engines can make controlled substances appear easier to access than they actually are.
A website might advertise:
- Ketamine products
- Ketamine therapy
- Ketamine treatment
- Ketamine delivery
- Ketamine for mental health
- Ketamine for depression
But an online listing does not automatically mean that a product or seller is legally authorized.
Health Canada states that ketamine is controlled under Schedule I of the Controlled Drugs and Substances Act and that activities such as sale, possession, and production are illegal unless authorized for medical, scientific, or industrial purposes.
This distinction is especially important when researching ketamine online in Canada.
What About Online Ketamine Treatment?
There is an important difference between purchasing a controlled substance from an unauthorized online source and receiving legitimate healthcare through an authorized medical pathway.
A legitimate medical process involves healthcare professionals assessing whether a treatment is appropriate.
Depending on the treatment, this may involve:
- Medical assessment
- Review of medical history
- Evaluation of previous treatments
- Discussion of potential risks
- Appropriate prescribing
- Professional monitoring
- Follow-up care
This is very different from ordering an unknown substance from an online seller.
The Future of Ketamine Research in Canada
Ketamine research is likely to remain an important area of interest.
Researchers are continuing to investigate:
- Depression
- Treatment-resistant depression
- Pain
- Neuroplasticity
- Dissociation
- Rapid-acting psychiatric treatments
- Comparisons with established treatments
The Canadian clinical trial database demonstrates that ketamine research remains active, including studies comparing ketamine with other treatments for depression.
At the same time, Canadian mental health experts emphasize that investigational treatments should not automatically replace established evidence-based treatments.
Health Canada’s Scientific Advisory Committee on Mental Health Disorders notes that IV ketamine and intranasal esketamine have been considered in cases of treatment resistance, while also emphasizing appropriate use of established treatments and monitoring.
Is Ketamine a Psychedelic?
Ketamine is often described as a psychedelic or psychedelic-adjacent substance because it can dramatically alter perception and consciousness.
Technically, however, ketamine is best classified as a dissociative anesthetic.
Its characteristic effect is dissociation rather than the classic psychedelic mechanism associated with substances such as psilocybin or LSD.
This distinction matters because the substances have different pharmacology, effects, therapeutic research, and safety considerations.
Is Ketamine Legal in Canada?
Ketamine is legal for authorized medical purposes in Canada.
However, it is a controlled substance.
Health Canada states that ketamine is controlled under Schedule I of the Controlled Drugs and Substances Act and that unauthorized sale, possession, or production is illegal.
Authorized medical and scientific activities operate within specific regulatory frameworks.
Therefore, the fact that ketamine has legitimate medical uses does not mean that anyone can legally purchase or possess it outside those authorized pathways.
Frequently Asked Questions About Ketamine in Canada
What is ketamine?
Ketamine is a fast-acting dissociative anesthetic used medically in Canada. It can alter perception, pain sensation, consciousness, and awareness.
Is ketamine a psychedelic?
Ketamine is primarily classified as a dissociative anesthetic. Its ability to alter consciousness can produce experiences that overlap with some psychedelic effects.
Is ketamine legal in Canada?
Ketamine has legitimate medical uses but is a controlled substance. Unauthorized sale, possession, and production are illegal unless specifically authorized.
Is ketamine used for depression?
Ketamine and esketamine are being studied and used in specific clinical contexts related to depression. Esketamine has an authorized indication in Canada for certain cases of major depressive disorder under controlled conditions.
What is esketamine?
Esketamine is one of the two molecular forms that make up racemic ketamine. In Canada, esketamine is authorized as a nasal spray under the brand name Spravato for specific patients with major depressive disorder.
Can ketamine be addictive?
Yes. Health Canada states that ketamine can be addictive and that regular use may lead to tolerance and withdrawal symptoms.
What are the risks of ketamine?
Risks can include confusion, impaired coordination, increased blood pressure and heart rate, hallucinations, loss of consciousness, breathing difficulties, and longer-term bladder and cognitive problems.
Final Thoughts
Ketamine has evolved from a well-established anesthetic into one of the most closely discussed substances in modern mental health research.
Its dissociative properties have generated interest in neuroscience, while ketamine and esketamine have become subjects of research and clinical use in specific psychiatric settings.
But the growing conversation should not obscure the risks.
Ketamine is a controlled substance in Canada, and unauthorized sale, possession, and production are illegal. Legitimate medical use takes place through appropriate healthcare and regulatory pathways.
For Canadians researching ketamine, the most useful approach is to distinguish between medical ketamine, esketamine, clinical research, and illicit products.
As research continues, ketamine may remain an important part of the evolving conversation around rapid-acting psychiatric treatments. But responsible discussion requires both an understanding of its potential medical applications and a realistic view of its risks and legal status.
